BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 579346)

  • 1. Antitumor activity of new anthracycline antibiotics, aclacinomycin-A and its analogs, and their toxicity.
    Hori S; Shirai M; Hirano S; Oki T; Inui T; Tsukagoshi S; Ishizuka M; Takeuchi T; Umezawa H
    Gan; 1977 Oct; 68(5):685-90. PubMed ID: 579346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental evaluation of anthracycline analogs.
    Casazza AM
    Cancer Treat Rep; 1979 May; 63(5):835-44. PubMed ID: 455325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New anthracycline antibiotics and derivatives].
    Tatsuta K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2640-52. PubMed ID: 6594977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiotoxicity of daunorubicin and aclacinomycin A in patients with acute leukemia].
    Haruyama H; Shimazaki C; Nakanishi S; Hamami T; Nisio A; Isemura T; Katsume H; Nakagawa M; Ijichi H
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):516-21. PubMed ID: 6964037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New anthracycline antibiotics.
    Oki T
    Jpn J Antibiot; 1977 Dec; 30 Suppl():70-84. PubMed ID: 612711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Models of preclinical studies of anthracyclines].
    Fizames C
    Pathol Biol (Paris); 1987 Jan; 35(1):41-8. PubMed ID: 3550611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental studies of new anthracyclines: aclacinomycin, THP-adriamycin and ditrisarubicins.
    Umezawa K; Kunimoto S; Takeuchi T
    Biomed Pharmacother; 1987; 41(5):206-13. PubMed ID: 2444279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination chemotherapy with a new anthracycline glycoside, aclacinomycin-A, and active drugs for malignant lymphomas in P388 mouse leukemia system.
    Fujimoto S; Inagaki J; Horikoshi N; Ogawa M
    Gan; 1979 Aug; 70(4):411-20. PubMed ID: 92432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-trifluoroacetyladriamycin-14-valerate, an analog with greater experimental antitumor activity and less toxicity than adriamycin.
    Israel M; Modest EJ; Frei E
    Cancer Res; 1975 May; 35(5):1365-8. PubMed ID: 1054622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antitumor activity of 4-demethoxyadriamycin and 4-demethoxy-4' -epiadriamycin.
    Di Marco A; Casazza AM; Giuliani F; Pratesi G; Arcamone F; Bernardi L; Franchi G; Giardino P; Patelli B; Penco S
    Cancer Treat Rep; 1978 Mar; 62(3):375-80. PubMed ID: 647696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of N-trifuloroacetyladriamycin-14-valerate.
    Pratesi G; Casazza AM; Di Marco A
    Cancer Treat Rep; 1978 Jan; 62(1):105-10. PubMed ID: 626988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of host defense merchanisms in the antitumor activity of adriamycin and daunomycin in mice.
    Mantovani A; Polentarutti N; Luini W; Peri G; Spreafico F
    J Natl Cancer Inst; 1979 Jul; 63(1):61-6. PubMed ID: 286835
    [No Abstract]   [Full Text] [Related]  

  • 13. Electron microscopic studies of the heart and light microscopic studies of the skin after treatment of golden hamsters with adriamycin, detorubicin, AD-32, and aclacinomycin.
    Dantchev D; Slioussartchouk V; Paintrand M; Hayat M; Bourut C; Mathé G
    Cancer Treat Rep; 1979 May; 63(5):875-88. PubMed ID: 455329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antineoplastic antibiotics from Streptomycetes].
    Strauss D
    Arzneimittelforschung; 1970 Mar; 20(3):301-16. PubMed ID: 4315126
    [No Abstract]   [Full Text] [Related]  

  • 15. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part I - Antitumor antibiotics and their derivatives.
    Umezawa H
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):12-8. PubMed ID: 6173340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biosynthesis of anthracycline antibiotics by Streptomyces galilaeus. II. Structure of new anthracycline antibiotics obtained by microbial glycosidation and biological activity.
    Matsuzawa Y; Yoshimoto A; Oki T; Naganawa H; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1980 Nov; 33(11):1341-7. PubMed ID: 6941953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor and immunosuppressive activities of lankacidin-group antibiotics: structure-activity relationships.
    Oostu K; Matsumoto T; Harada S; Kishi T
    Cancer Chemother Rep; 1975; 59(5):919-28. PubMed ID: 1148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anthracycline antibiotics with high liposome entrapment: structural features and biological activity.
    Perez-Soler R; Priebe W
    Cancer Res; 1990 Jul; 50(14):4260-6. PubMed ID: 2194651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Toxicologic study and experimental antitumor activity of rubidomycin (13,057 R.P.)].
    Maral R; Bourat G; Ducrot R; Fournel J; Ganter P; Julou L; Koenig F; Myon J; Pascal S; Pasquet J; Populaire P; de Ratuld Y; Werner GH
    Pathol Biol; 1967 Oct; 15(19):903-8. PubMed ID: 4296784
    [No Abstract]   [Full Text] [Related]  

  • 20. [Preparation of dihydrocarminomycin and a comparison of its antitumor activity with the activity of carminomycin].
    Povarov LS; Shorin VA; Bazhanov VS; Shepelevtseva NG
    Antibiotiki; 1976 Nov; 21(11):1008-11. PubMed ID: 1037188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.